SEC Comment Letter for PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744) (PPBT) — May 20, 2020
PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744)
Date: May 20, 2020 · CIK: 0001614744 · Accession: 0000000000-20-004517
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-238229
Letter
United States securities and exchange commission logo May 20, 2020 Avraham Ben-Tzvi, Adv. Group Chief Legal Officer Kitov Pharma Ltd. 132 Menachem Begin Road Tel Aviv 6701101 Israel Re:Kitov Pharma Ltd. Registration Statement on Form F-3 Filed May 13, 2020 File No. 333-238229 Dear Mr. Ben-Tzvi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Laura Crotty at (202) 551-7614 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rick A. Werner
Show Raw Text
United States securities and exchange commission logo
May 20, 2020
Avraham Ben-Tzvi, Adv.
Group Chief Legal Officer
Kitov Pharma Ltd.
132 Menachem Begin Road
Tel Aviv 6701101
Israel
Re:Kitov Pharma Ltd.
Registration Statement on Form F-3
Filed May 13, 2020
File No. 333-238229
Dear Mr. Ben-Tzvi:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Laura Crotty at (202) 551-7614 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Rick A. Werner